Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00143338 · ClinicalTrials.gov registry record · Phase 2
To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.
A Phase 2 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT00143338 is a Phase 2 study that has completed, run by Pfizer. The registered enrollment target is 20 participants.
The verdict
NCT00143338, a Phase 2 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
To examine the lung when people with diabetes take an inhaled form of insulin, compared to subcutaneous insulin.
Interventions
- DRUG Inhaled insulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2004-11 |
| Est. Completion | 2006-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00143338
The ClinicalTrials.gov registry entry for NCT00143338 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Inhaled insulin is the first listed.
NCT00143338 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00143338 about?
NCT00143338 is a clinical study titled "To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.". To examine the lung when people with diabetes take an inhaled form of insulin, compared to subcutaneous insulin.
What is the current status of trial NCT00143338?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2004-11. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00143338?
The interventions under investigation include: Inhaled insulin (DRUG).
Who is sponsoring clinical trial NCT00143338?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.